The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Silver in Health Care: Antimicrobial Effects and Safety in Use
Abstract
Silver has a long and intriguing history as an antibiotic in human health care. It has been developed for use in water purification, wound care, bone prostheses, reconstructive orthopaedic surgery, cardiac devices, catheters and surgical appliances. Advancing biotechnology has enabled incorporation of ionizable silver into fabrics for clinical use to reduce the risk of nosocomial infections and for personal hygiene. The antimicrobial action of silver or silver compounds is proportional to the bioactive silver ion (Ag(+)) released and its availability to interact with bacterial or fungal cell membranes. Silver metal and inorganic silver compounds ionize in the presence of water, body fluids or tissue exudates. The silver ion is biologically active and readily interacts with proteins, amino acid residues, free anions and receptors on mammalian and eukaryotic cell membranes. Bacterial (and probably fungal) sensitivity to silver is genetically determined and relates to the levels of intracellular silver uptake and its ability to interact and irreversibly denature key enzyme systems. Silver exhibits low toxicity in the human body, and minimal risk is expected due to clinical exposure by inhalation, ingestion, dermal application or through the urological or haematogenous route. Chronic ingestion or inhalation of silver preparations (especially colloidal silver) can lead to deposition of silver metal/silver sulphide particles in the skin (argyria), eye (argyrosis) and other organs. These are not life-threatening conditions but cosmetically undesirable. Silver is absorbed into the human body and enters the systemic circulation as a protein complex to be eliminated by the liver and kidneys. Silver metabolism is modulated by induction and binding to metallothioneins. This complex mitigates the cellular toxicity of silver and contributes to tissue repair. Silver allergy is a known contra-indication for using silver in medical devices or antibiotic textiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silver I: its antibacterial properties and mechanism of action
Lansdown, A. B. G. (2002) · Journal of Wound Care · doi:10.12968/jowc.2002.11.4.26389 · Cited by 868
Self-citationLeonard, M., & Sollmann, T. (1937) · The American Journal of Nursing · doi:10.2307/3414059 · Cited by 535
Anti-Infective Efficacy of Silver-Coated Medical Prostheses
Darouiche, R. O. (1999) · Clinical Infectious Diseases · doi:10.1086/313561 · Cited by 195
Saint, S. K., Veenstra, D. L., Sullivan, S. D., Chenoweth, C. E., & Fendrick, A. M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2670 · Cited by 151
Role of antimicrobial central venous catheters for the prevention of associated infections
Elliott, T. S. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.441 · Cited by 26
Cited by
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
Chernousova, S., & Epple, M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205923 · Cited by 2,264
Nanosilver: A nanoproduct in medical application
Chen, X., & Schluesener, H. J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2007.10.004 · Cited by 1,888
Silver nanoparticles: Synthesis, medical applications and biosafety
Xu, L., Wang, Y.-Y., Huang, J., Chen, C.-Y., Wang, Z.-X., & Xie, H. (2020) · Theranostics · doi:10.7150/thno.45413 · Cited by 1,315
Eliaz, N., & Metoki, N. (2017) · Materials · doi:10.3390/ma10040334 · Cited by 1,088
Introduction to metallic nanoparticles
Mody, V., Siwale, R., Singh, A., & Mody, H. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72127 · Cited by 1,025
Metadata
- Authors
- Lansdown, A. B. G.
- Venue
- Current Problems in Dermatology
- Publisher
- KARGER
- Published
- 2006
- Volume
- 33
- Pages
- 17-34
- ISSN
- 1040-0486 (ISSN-L)
- OpenAlex
- W2139652646
- Cited by
- 802
- References
- 5
- FWCI
- 67.69
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.